QS Investors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$1.3M Sell
7,072
-166
-2% -$30.5K 0.02% 426
2021
Q1
$1.11M Sell
7,238
-567
-7% -$86.7K 0.01% 509
2020
Q4
$1.22M Sell
7,805
-228
-3% -$35.6K 0.01% 437
2020
Q3
$920K Sell
8,033
-202
-2% -$23.1K 0.01% 464
2020
Q2
$925K Sell
8,235
-500
-6% -$56.2K 0.01% 745
2020
Q1
$785K Hold
8,735
0.01% 733
2019
Q4
$942K Sell
8,735
-507
-5% -$54.7K 0.01% 794
2019
Q3
$906K Hold
9,242
0.01% 803
2019
Q2
$1.21M Hold
9,242
0.01% 746
2019
Q1
$1.25M Sell
9,242
-280
-3% -$37.9K 0.01% 753
2018
Q4
$928K Sell
9,522
-5,384
-36% -$525K 0.01% 783
2018
Q3
$2.07M Sell
14,906
-6,457
-30% -$898K 0.02% 614
2018
Q2
$2.65M Sell
21,363
-47
-0.2% -$5.84K 0.03% 512
2018
Q1
$2.39M Sell
21,410
-36
-0.2% -$4.01K 0.02% 520
2017
Q4
$2.57M Sell
21,446
-304
-1% -$36.4K 0.02% 518
2017
Q3
$3.05M Sell
21,750
-1,675
-7% -$235K 0.02% 467
2017
Q2
$2.85M Sell
23,425
-700
-3% -$85.2K 0.02% 486
2017
Q1
$2.93M Sell
24,125
-2,749
-10% -$333K 0.03% 480
2016
Q4
$3.29M Sell
26,874
-36
-0.1% -$4.41K 0.03% 461
2016
Q3
$3.3M Sell
26,910
-867
-3% -$106K 0.03% 512
2016
Q2
$3.24M Sell
27,777
-1,081
-4% -$126K 0.03% 519
2016
Q1
$4.02M Sell
28,858
-9,799
-25% -$1.36M 0.04% 462
2015
Q4
$7.37M Sell
38,657
-8,762
-18% -$1.67M 0.07% 259
2015
Q3
$7.42M Sell
47,419
-315
-0.7% -$49.3K 0.08% 237
2015
Q2
$8.63M Sell
47,734
-64,889
-58% -$11.7M 0.11% 234
2015
Q1
$19.5M Sell
112,623
-77,058
-41% -$13.4M 0.22% 95
2014
Q4
$35.1M Buy
189,681
+140,613
+287% +$26M 0.4% 50
2014
Q3
$8.14M Sell
49,068
-500
-1% -$82.9K 0.22% 112
2014
Q2
$7.75M Buy
49,568
+17,890
+56% +$2.8M 0.21% 120
2014
Q1
$4.82M Buy
31,678
+24,600
+348% +$3.74M 0.15% 158
2013
Q4
$942K Sell
7,078
-900
-11% -$120K 0.04% 327
2013
Q3
$927K Sell
7,978
-28,722
-78% -$3.34M 0.04% 340
2013
Q2
$3.41M Buy
+36,700
New +$3.41M 0.12% 219